NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect [Yahoo! Finance]
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. (NYSE: NNVC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect [Yahoo! Finance]